Across TCGA pan-cancer cohorts, CST13P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated CST13P data layer compared with 11 for mass-spec protein.

The strongest signal is observed in sarcoma (SARC), where higher CST13P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CST13P expression acts as an unfavorable survival marker.

SARC are the cancer types where CST13P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	OS	Median	All	0.281	0.745	.046	3	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: CST13P tumor-vs-normal RNA expression · all CST13P data types